You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations

Article metrics

Article menu

Download PDFPDF

Case Report
Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2026

AbstractFullPdf
Dec 2019440
Jan 2020772
Feb 2020552
Mar 2020663
Apr 202020207
May 202010103
Jun 202010105
Jul 202017173
Aug 2020773
Sep 202028287
Oct 202032334
Nov 202025253
Dec 202021218
Jan 202117176
Feb 202114142
Mar 202127276
Apr 202113135
May 202119197
Jun 202117174
Jul 2021181811
Aug 2021664
Sep 202122227
Oct 202110105
Nov 202114143
Dec 202128289
Jan 202218192
Feb 202212122
Mar 202226268
Apr 202232342
May 202224257
Jun 202232337
Jul 202228294
Aug 2022505510
Sep 2022394132
Oct 202231314
Nov 2022171916
Dec 202224247
Jan 202333332
Feb 202355553
Mar 2023171810
Apr 2023667
May 2023554
Jun 202312125
Jul 202314146
Aug 202316171
Sep 202315155
Oct 202319197
Nov 202324246
Dec 202328296
Jan 202447482
Feb 202424240
Mar 202418188
Apr 202415147
May 2024181810
Jun 202420197
Jul 2024262710
Aug 202421206
Sep 2024191912
Oct 2024151510
Nov 202427289
Dec 2024212312
Jan 2025161612
Feb 202519198
Mar 2025191916
Apr 2025525210
May 2025161611
Jun 202517176
Jul 2025110
Mar 2026110
Total13861407438